Dexmedetomidine and Midazolam Nebulization as Sedation During Cesarean Delivery in Pre-eclampsia
Procedural Sedation

About this trial
This is an interventional treatment trial for Procedural Sedation
Eligibility Criteria
Inclusion Criteria:
- Age: 21-38 years old.
- Mild and moderate preeclampsia parturient.
- American Society of AnesthesiologistPhysical status II.
- Body Mass Index (BMI) (25-35kg/m²).
- Type of operations: elective cesarean section under spinal anesthesia.
- Written informed consent from the parturient.
Exclusion Criteria:
- Altered mental state.
- Women with known history of allergy to study drugs.
- Women with uncontrolled diabetes mellitus, bleeding, coagulation disorders, advanced hepatic, renal, cardiovascular, respiratory disease and neuropsychiatric disorders.
- Patients receiving anticonvulsants or antidepressants.
- Sever preeclampsia, intrauterine growth restriction or fetal compromise.
Sites / Locations
- Zagazig University, Faculty of medicineRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
nebulized dexmedetomidine
nebulized midazolam
parturient will receive nebulized 3ug/kg dexmedetomidine diluted in normal saline (0.9%) solution till total volume of nebulized solution will become 5 ml and will be nebulized by a standard hospital jet nebulizer via mouthpiece, with a continuous flow of 100% oxygen at 6 L/min. for 15 minutes, and the treatment will be stopped when the nebulizer will be began to sputter.
parturient will receive nebulized 0.2 mg/kg midazolam diluted in normal saline (0.9%) solution till total volume of nebulized solution will become 5 ml and will be nebulized by a standard hospital jet nebulizer via mouthpiece, with a continuous flow of 100% oxygen at 6 L/min. for 15 minutes, and the treatment will be stopped when the nebulizer will be began to sputter.